Düsseldorf/Orlando (U.S.), March 15, 2018. Gerresheimer’s booth at the PDA Annual Meeting – to be held at the Loews Sapphire Falls Resort in Orlando from March 19 to 21 – is to focus on innovative glass and plastic vials for parenteral drugs that place high demands on the barrier properties and, by extension, the safety of their primary packaging.
Gerresheimer has invested many years in developing and producing its plastic MultiShell vials and glass Gx Elite vials in order to offer its customers primary packaging solutions that are ideal for sensitive active substances.
“It is absolutely crucial for drugs to be packaged properly in order to ensure drug stability,” says Edward Troy, Vice President Sales & Marketing and product expert for glass. “The question of whether to use glass or plastic vials depends on the application. We aim to work with our customers to find the best possible solution for their parenteral drugs.”
Gx Elite glass vials – glass of the very highest quality
Gx Elite vials’ quality and performance is a result of proprietary techniques employed in the manufacturing process. As a result of these proprietary techniques, the Gx Elite vials have a significant improvement in glass strength and reduced cosmetic defects. A vial which resists delamination protecting the valuable drug product.
“The kind of powerful active ingredients that are being developed nowadays need shatter-resistant packaging and improved barrier protection,” says Franck Langet, explaining the properties of the Gx MultiShell vial. With its innovative multilayer structure made from COP and PA, this transparent vial is a unique packaging solution that meets all these requirements. Gerresheimer offers vials holding 2, 5, 10, 15, 50, and 100 ml, which are also available as ready-to-use versions including validated gamma sterilization. Gerresheimer supplies both COP multilayer and monolayer containers.
Ultra-modern production processes – worldwide standards
Gerresheimer operates with the world’s latest technologies and monitoring processes from the development stage right through to production and packing for delivery. Gerresheimer uses cutting-edge clean room technology to guarantee optimum cleanliness for its products in terms of particles and germs. With bases in Europe, Asia, and the Americas, Gerresheimer specializes in manufacturing primary packaging for pharmaceuticals in line with the relevant pharmacopeias. All its factories are currently certified to standards including ISO 9001.
Gx and MultiShell are registered trademarks of the Gerresheimer Group.
About Gerresheimer
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.